Publication: Síntesis enzimática de fármacos antivirales: vacuna contra el VIH
Loading...
Official URL
Full text at PDC
Publication Date
2016
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
El síndrome de inmunodeficiencia humana aquirida (SIDA) es un problema en la salud pública a nivel mundial al que se destinan recursos tanto ecónomicos como humanos. Por este motivo es importante tener distintos métodos para atajar esta enfermedad, desde un tratamiento hasta la prevención de la infección por medio de una vacuna. Hasta ahora se han llevado a cabo diversos estudios sobre la posible obtención de una vacuna eficaz. Sin embargo este campo sigue siendo bastante desconocido a pesar de los avances realizados. En la actualidad una de las estrategias más prometedoras es la producción mediante métodos químico-enzimáticos de glicoproteínas que formarán parte de la vacuna.
Acquired immunodeficiency syndrome (AIDS) is a major problem in public health all over the world, so lots of economic and human resources are assigned. That is why is important to have differents methods to face this disease, from a treatment to a way of prevention by a vaccine. Until now numerous studies have been made about the posible efficient vaccine. However this field is still very unknown despite the progresses achieved. Nowadays chemoenzymatic synthesis highlights to obtain glycoproteins to be part of the vaccine.
Acquired immunodeficiency syndrome (AIDS) is a major problem in public health all over the world, so lots of economic and human resources are assigned. That is why is important to have differents methods to face this disease, from a treatment to a way of prevention by a vaccine. Until now numerous studies have been made about the posible efficient vaccine. However this field is still very unknown despite the progresses achieved. Nowadays chemoenzymatic synthesis highlights to obtain glycoproteins to be part of the vaccine.